Bayer's Yaz Ads 'Misleading:' FDA

Law360, New York (October 8, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration has chastised Bayer AG over two television commercials for Yaz, saying the ads over-promise the birth control pill's benefits and downplay serious risks associated with the drug.

These alleged violations are concerning from a public health perspective because they encourage the use of Yaz in circumstances other than those for which the drug has been approved, the agency told Bayer's president and chief executive officer Reinhard Franzen in an Oct. 3 letter, which the FDA posted on its Web site...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.